推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER GENE THERAPY

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER GENE THE最新评论:投稿完成后1天状态变成continue partial submission,点进去发现又让上传文件,请问各位大神这是什么情况? (2024-09-07)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER GENE THERAPY期刊基本信息Hello,您是该期刊的第56711位访客


基本信息 登录收藏
期刊名字CANCER GENE THERAPYCANCER GENE THERAPY

CANCER GENE THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.6
52人评分
我要评分

声誉
8.7

影响力
6.3

速度
9.0

期刊ISSN0929-1903
微信扫码收藏此期刊
E-ISSN1476-5500
2023-2024最新影响因子
(数据来源于搜索引擎)
4.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:4.964
2023-2024自引率2.10%点击查看自引率趋势图
五年影响因子4.9
JCI期刊引文指标 1.1
h-index 80
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
10.201.4570.903
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Biology
Q171 / 410
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Medicine
Q135 / 178
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q149 / 230

期刊简介
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
期刊官方网站https://www.nature.com/cgt
期刊投稿网址https://mts-cgt.nature.com/
作者指南网址https://www.nature.com/cgt/authors-and-referees
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER GENE THERAPY的语言要求,还能让CANCER GENE THERAPY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER GENE THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No

备注:Archive content is freely available after five years.
通讯方式NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
出版商Springer Nature
涉及的研究方向医学-生物工程与应用微生物
出版国家或地区ENGLAND
出版语言English
出版周期Monthly
出版年份1999
年文章数 123点击查看年文章数趋势图
Gold OA文章占比37.11%
研究类文章占比:
文章 ÷(文章 + 综述)
85.37%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ127/174
学科:GENETICS & HEREDITYSCIEQ129/191
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ145/189
学科:ONCOLOGYSCIEQ170/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ125/174
学科:GENETICS & HEREDITYSCIEQ136/191
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ143/189
学科:ONCOLOGYSCIEQ169/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区3区1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
2区3区2区
GENETICS & HEREDITY
遗传学
4区3区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区1区3区
ONCOLOGY
肿瘤学
4区3区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
2区3区2区
GENETICS & HEREDITY
遗传学
3区2区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区3区3区
ONCOLOGY
肿瘤学
1区3区3区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
4区1区2区
GENETICS & HEREDITY
遗传学
2区4区2区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
4区2区3区
ONCOLOGY
肿瘤学
2区2区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0929-1903%5BISSN%5D
平均审稿速度网友分享经验:
偏慢,4-8周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER GENE THERAPY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER GENE THERAPY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER GENE THERAPY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER GENE THERAPY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS DRUG DISCOVERY289137.40
    NATURE BIOTECHNOLOGY39963.00
    TRENDS IN BIOTECHNOLOGY19528.60
    BIOTECHNOLOGY ADVANCES16125.50
    MOLECULAR THERAPY15819.20
    PLANT BIOTECHNOLOGY JOURNAL9620.50
    CRITICAL REVIEWS IN BIOTECHNOLOGY7920.80
    METABOLIC ENGINEERING10115.60
    Biotechnology for Biofuels7515.70
    FOOD MICROBIOLOGY10311.30
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE660215
    BIOMATERIALS555470
    BIOMEDICINE & PHARMACOTHERAPY533660
    Frontiers in Pharmacology501462
    Journal of Materials Chemistry B492896
    Frontiers in Immunology477337
    COMPUTERS IN BIOLOGY AND MEDICINE454164
    JOURNAL OF ETHNOPHARMACOLOGY452204
    COLLOIDS AND SURFACES B-BIOINTERFACES431122
    Frontiers in Oncology425269
  •  

    CANCER GENE THERAPY CANCER GENE THERAPY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation

    Author: He, Yuan; Han, Pengyong; Chen, Chuang; Xie, Shuzhe; Zhang, Huiqing; Song, Yingming; Hu, Hao; Zhao, Qiang; Lian, Changhong
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 4, pp. 559-566. DOI: 10.1038/s41417-021-00382-w
        PubMed      DOI
    2.FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma

    Author: Wang, Chong; Li, Lingling; Li, Mengya; Wang, Weiqiong; Jiang, Zhongxing
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 4, pp. 622-628. DOI: 10.1038/s41417-022-00429-6
        PubMed      DOI
    3.SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide

    Author: Du, Li; Liu, Wei; Pichiorri, Flavia; Rosen, Steven T.
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 4, pp. 567-574. DOI: 10.1038/s41417-022-00450-9
        PubMed      DOI
    4.Protein post-translational modifications in the regulation of cancer hallmarks

    Author: Wang, Haiying; Yang, Liqian; Liu, Minghui; Luo, Jianyuan
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 4, pp. 529-547. DOI: 10.1038/s41417-022-00464-3
        PubMed      DOI
    5.Application of ATAC-seq in tumor-specific T cell exhaustion

    Author: Chen, Chufeng; Liu, Jiaying; Chen, Yidong; Lin, Anqi; Mou, Weiming; Zhu, Lingxuan; Yang, Tao; Cheng, Quan; Zhang, Jian; Luo, Peng
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 1, pp. 1-10. DOI: 10.1038/s41417-022-00495-w
        PubMed      DOI
    6.Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c

    Author: Yao, Jian; Hui, Jian-wen; Chen, Yan-jun; Luo, Dong-yang; Yan, Jiang-shu; Zhang, Yi-fan; Lan, Yuan-xiang; Yan, Xiu-rui; Wang, Zhi-hua; Fan, Heng; Xia, Xe-chun
    Journal: CANCER GENE THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41417-023-00611-4
        PubMed      DOI
    7.CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages

    Author: Wang, Jia-Bin; Gao, You-Xin; Ye, Yin-Hua; Lin, Tong-Xing; Li, Ping; Lin, Jian-Xian; Chen, Qi-Yue; Cao, Long-Long; Lin, Mi; Tu, Ru-Hong; Lin, Ju-Li; Huang, Ze-Ning; Zheng, Hua-Long; Xie, Jian-Wei; Zheng, Chao-Hui; Huang, Chang-Ming
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 1, pp. 22-37. DOI: 10.1038/s41417-022-00515-9
        PubMed      DOI
    8.ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer

    Author: Liu, Xiaoli; Zhang, Junhua; Ju, Shuang; Liu, Lu; Sun, Yu; Guo, Lingyu; Zhen, Qianwei; Han, Sai; Lu, Wei; Zhang, Youzhong
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 1, pp. 62-73. DOI: 10.1038/s41417-022-00525-7
        PubMed      DOI
    9.Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT

    Author: Zheng, Yan; Jia, Huiqing; Wang, Ping; Liu, Litong; Chen, Zhaoxv; Xing, Xiaoming; Wang, Jin; Tan, Xiaohua; Wang, Chengqin
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 1, pp. 74-84. DOI: 10.1038/s41417-022-00517-7
        PubMed      DOI
    10.MCPIP1 Suppresses the NF-kappa B Signaling Pathway Through Negative Regulation of K63-Linked Ubiquitylation of TRAF6 in Colorectal Cancer

    Author: Ye, Wen; Cui, Yachao; Rong, Jian; Huang, Wenlin; Zheng, Zhousan; Li, Anqi; Li, Yingchang
    Journal: CANCER GENE THERAPY. 2023; Vol. 30, Issue 1, pp. 96-107. DOI: 10.1038/s41417-022-00528-4
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共69


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室